newsfilter
← Latest News
ACCESS Newswire·

Lexaria's Human Study GLP-1-H26-7 Reaches Full Enrollment and Continues Dosing on Schedule

KELOWNA, BC / ACCESS Newswire / October 21, 2026 / Lexaria Bioscience Corp. , a global innovator in drug delivery platforms, reports that full enrollment has